Clinical trial
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
NCT00105105 · Corcept Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00105105 |
|---|---|
| Title | Mifepristone as Adjunctive Therapy in Alzheimer's Disease |
| Official title | A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease |
| Lead sponsor | Corcept Therapeutics, Industry |
| Collaborators | Institute for the Study of Aging (ISOA) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Mifepristone |
| Enrollment | 160 |
| Start date | Apr 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Mar 7, 2005 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: